Skip to Main Content

Author Details

Khashayar Asadi
Austin Hospital
2015
24
8
PMIDPaper TitleJournal TitlePublished Year
36221184Gallbladder-associated ectopic liver tissue during cholecystectomy.ANZ J Surg2023
37559603Real-world challenges in undertaking <i>NTRK</i> fusion testing in non-small cell lung cancer.J Thorac Dis2023
37833206Real-world prevalence of PD-L1 expression in non-small cell lung cancer: an Australia-wide multi-centre retrospective observational study.Pathology2023
36825075Kikuchi's Disease Diagnosed by an Excisional Biopsy in a Patient With COVID-19.Cureus2023
34951153Angiotensin Converting Enzyme-2 Therapy Improves Liver Fibrosis and Glycemic Control in Diabetic Mice With Fatty Liver.Hepatol Commun2022
35663668Herb-Induced Liver Injury: A Report on Two Australian Cases.Cureus2022
36273482Searching for a cause of a gastric ulcer in case of common variable immunodeficiency: cytomegalovirus.Lancet2022
35191578Giant pseudosarcomatous polyp of the gallbladder.ANZ J Surg2022
32232397Ustekinumab is a Safe and Effective Biological Agent for Crohn's Disease in a Liver Transplant Patient.J Crohns Colitis2020
31883410Hepatitis B virus activity is not associated with degree of liver steatosis in patients with hepatitis B-related chronic liver disease.Liver Int2020
33035778Analysis of angiogenic and stromal biomarkers in a large malignant mesothelioma cohort.Lung Cancer2020
32912846Case of nivolumab-induced sclerosing cholangitis: lessons from long-term follow-up.BMJ Open Gastroenterol2020
32540558NTRK and ALK rearrangements in malignant pleural mesothelioma, pulmonary neuroendocrine tumours and non-small cell lung cancer.Lung Cancer2020
31832573Liver-Targeted Angiotensin Converting Enzyme 2 Therapy Inhibits Chronic Biliary Fibrosis in Multiple Drug-Resistant Gene 2-Knockout Mice.Hepatol Commun2019
29754273Drug-induced liver failure due to rivaroxaban.Ann Hematol2018
30093472Hepatic angiosarcoma as a cause of acute liver failure.BMJ Case Rep2018
28403984Elastosis perforans serpiginosa in a patient with Wilson's disease.Lancet Gastroenterol Hepatol2017
28280702Mycophenolate mofetil toxicity mimicking acute cellular rejection in a small intestinal transplant.World J Transplant2017
28257959The Immune Microenvironment, Genome-wide Copy Number Aberrations, and Survival in Mesothelioma.J Thorac Oncol2017
28086198Gastric adenocarinoma of the upper oesophagus: A literature review and case report.Int J Surg Case Rep2017
27104612PD-L1 and Tumor Infiltrating Lymphocytes as Prognostic Markers in Resected NSCLC.PLoS One2016
27780599Calretinin but not caveolin-1 correlates with tumour histology and survival in malignant mesothelioma.Pathology2016
25807853Renal allograft re-use and herpetic re-infection.Nephrology (Carlton)2015
26125443Vascular endothelial growth factor D expression is a potential biomarker of bevacizumab benefit in colorectal cancer.Br J Cancer2015
  • 1 - 24 of 24

Recommended Authors

Min Kyu Kang
Yeungnam University College of Medicine
Career Start Year 2018
Number of shared co-authors 0
Kaitlin C McLoughlin
Memorial Sloan Kettering Cancer Center
Career Start Year 2017
Number of shared co-authors 0
Erika Hissong
New York-Presbyterian Hospital/Weill Cornell Medicine
Career Start Year 2015
Number of shared co-authors 0
Gaurav Syal
university of california san diego
Career Start Year 2012
Number of shared co-authors 0
Anouar Teriaky
Western University
Career Start Year 2011
Number of shared co-authors 0
Alia Albawardi
College of Medicine and Health Sciences, United Arab Emirates University
Career Start Year 2010
Number of shared co-authors 1
Neil Rajoriya
Queen Elizabeth Hospital Birmingham
Career Start Year 2009
Number of shared co-authors 0
Bita V Naini
university of california los angeles Medical Center
Career Start Year 2008
Number of shared co-authors 0
Christopher Koh
Clinical Research Section
Career Start Year 2008
Number of shared co-authors 0
Saeeda Almarzooqi
College of Medicine and Health Sciences, United Arab Emirates University
Career Start Year 2008
Number of shared co-authors 1
Jochen K Lennerz
Massachusetts General Hospital/Harvard Medical School
Career Start Year 2004
Number of shared co-authors 0
Thomas Longerich
Institute of Pathology, University Hospital Heidelberg
Career Start Year 2004
Number of shared co-authors 0
Reza Ghasemi
Washington University School of Medicine
Career Start Year 2003
Number of shared co-authors 0
Ana Lleo
Humanitas University
Career Start Year 2003
Number of shared co-authors 0
Woo Jin Chung
Keimyung University School of Medicine
Career Start Year 2002
Number of shared co-authors 0
Zubair Khan
University of Texas at Houston Health Science Center
Career Start Year 2002
Number of shared co-authors 0
Arndt Vogel
Clinic for Gastroenterology, Medical University Hannover
Career Start Year 2001
Number of shared co-authors 0
Won Young Tak
Kyungpook National University
Career Start Year 2001
Number of shared co-authors 0
Arief A Suriawinata
Dartmouth Hitchcock Medical Center
Career Start Year 1999
Number of shared co-authors 0
Sharad C Mathur
Kansas City VA Medical Center
Career Start Year 1998
Number of shared co-authors 0
Theo Heller
National Institute of Diabetes and Digestive and Kidney Diseases
Career Start Year 1996
Number of shared co-authors 0
Udo Rudloff
Center for Cancer Research, National Cancer Institute
Career Start Year 1994
Number of shared co-authors 0
Andrew D Clouston
University of Queensland
Career Start Year 1993
Number of shared co-authors 0
Hyun-Soo Kim
Wonju Severance Christian Hospital
Career Start Year 1993
Number of shared co-authors 0
Peter Schirmacher
Institute of Pathology, University Hospital Heidelberg
Career Start Year 1989
Number of shared co-authors 1
Yoshiyuki Takei
Mie University
Career Start Year 1988
Number of shared co-authors 0
Jose A Lopez-Martin
Hospital Universitario 12 de Octubre
Career Start Year 1988
Number of shared co-authors 0
Richard D Schulick
University of Colorado School of Medicine
Career Start Year 1983
Number of shared co-authors 0
Luis Ib????ez
Gregorio Maranon University Hospital
Career Start Year 1980
Number of shared co-authors 0
Zachary Goodman
Center for Liver Diseases, Inova Fairfax Hospital
Career Start Year 1975
Number of shared co-authors 0

Collaborators

Thomas John
Peter MacCallum Cancer Centre
Co-authored papers 6
Carmel Murone
Olivia Newton-John Cancer Research Institute
Co-authored papers 5
Paul Mitchell
Olivia Newton-John Cancer Research Institute
Co-authored papers 4
Marzena Walkiewicz
Olivia Newton-John Cancer Research Institute
Co-authored papers 4
Bibhusal Thapa
Northern Hospital
Co-authored papers 4
Simon Knight
Churchill Hospital
Co-authored papers 3
Malaka Ameratunga
Australia Central Clinical School, Monash University
Co-authored papers 2
Xihui Lin
Kresge Eye Institute/Wayne State University Department of Ophthalmology
Co-authored papers 2
Stephen Barnett
Royal Melbourne Hospital
Co-authored papers 2
Paul C Boutros
University of California los angeles
Co-authored papers 2
Siddhartha Deb
Olivia Newton-John Cancer Research Institute
Co-authored papers 2
David N Watkins
Research Institute in Oncology and Hematology
Co-authored papers 2
Prudence A Russell
St Vincent's Hospital
Co-authored papers 1
Puey Ling Chia
Lee Kong Chian School of Medicine, Nanyang Technological University
Co-authored papers 1
Adriana Salcedo
University of Toronto
Co-authored papers 1
John M Mariadason
Olivia Newton-John Cancer Research Institute
Co-authored papers 1
Gareth Rivalland
Auckland City Hospital
Co-authored papers 1
Peter G Kerr
Co-authored papers 1
Release 1.2